CTOs on the Move

Pliant Therapeutics

www.pliantrx.com

 
Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. By harnessing the therapeutic potential of integrin biology and TGF-β modulation, Pliant aims to prevent or even reverse fibrosis to address the needs of many patients. The company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery. Pliant`s co-founders include world-renowned researchers from University of California, San Francisco (UCSF), who bring broad experience in fibrosis biology and small molecule chemistry. Together, the Pliant team is dedicated to translating scientific advances ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.pliantrx.com
  • 260 Littlefield Avenue
    South San Francisco, CA USA 94080
  • Phone: 650.481.6770

Executives

Name Title Contact Details
Tim Saunders
Head Of Information Technology Profile
Diane Ireland
Head of Facilities, IT and Operations Profile

Funding

Pliant Therapeutics raised $62M on 07/16/2018
Pliant Therapeutics raised $100M on 03/03/2020

Similar Companies

Cellular Engineering Technologies

Cellular Engineering Technologies is a Iowa City, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Proneuron Biotechnologies

Proneuron Biotechnologies is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Warner Health Care

Berkeley Premium Nutraceuticals currently offers six supplements to address issues including sexual health, fatigue, night vision, and cardiovascular health. The Company is also investigating new formulas to assist with other concerns, including prostate

Jaguar Health

Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

GFS Chemicals

GFS Chemicals is a Powell, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.